Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.7.0.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Operating activities    
Net income $ 80,194 $ 59,046
Adjustments to reconcile net income to cash provided by operating activities:    
Depreciation 56,975 48,839
Amortization of intangible and other assets and favorable/unfavorable leases 381 490
Amortization of long-term prepaid rents 493 471
Amortization of debt issue costs 1,529 1,286
Amortization of deferred revenues, deferred lease incentives and other (3,822) (5,243)
Impairment of long-lived assets 273 492
Share based awards compensation expense 3,241 5,118
(Gain) loss on sale of assets and other 834 (1,779)
Write-off of unamortized debt issue costs associated with early retirement of debt   2,369
Deferred lease expenses (347) (440)
Equity in income of affiliates (10,060) (7,142)
Deferred income tax expenses 8,889 (2,933)
Distributions from equity investees [1] 12,049 8,086
Changes in assets and liabilities and other (64) (40,947)
Net cash provided by operating activities 150,565 67,713
Investing activities    
Additions to theatre properties and equipment and other (91,187) (47,745)
Acquisition of theatres in the U.S.   (15,300)
Proceeds from sale of theatre properties and equipment and other 3,835 347
Proceeds from sale of marketable securities   13,451
Investments in joint ventures and other (228) (12)
Net cash used for investing activities (87,580) (49,259)
Financing activities    
Dividends paid to stockholders (33,760) (31,367)
Payroll taxes paid as a result of restricted stock withholdings (2,694) (5,610)
Proceeds from issuance of other Senior Notes, net of discount   222,750
Retirement of Senior Subordinated Notes   (200,000)
Repayments of long-term debt   (1,758)
Payments of debt issue costs   (3,675)
Payments on capital leases (4,989) (4,572)
Other (294) 1,503
Net cash used for financing activities (41,737) (22,729)
Effect of exchange rate changes on cash and cash equivalents 1,835 (372)
Increase (decrease) in cash and cash equivalents 23,083 (4,647)
Cash and cash equivalents:    
Beginning of period 561,235 588,539
End of period $ 584,318 $ 583,892
[1] Includes cash distributions received from equity investees that were recorded as a reduction of the respective investment balances.